RENOVORX, INC. Operating Cash Flow
RENOVORX, INC. (RNXT) reported Operating Cash Flow of -$6.58 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- RENOVORX, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.87M.
- RENOVORX, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.71M.
- RENOVORX, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.02M.
- RENOVORX, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$2.27M.
- RENOVORX, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$10.97M.
- RENOVORX, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$9.13M.
- RENOVORX, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$10.26M.
- RENOVORX, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$8.81M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$6.58M 10-Q · filed 2026-08-13 | -$9.60M derived: sum of 3 quarters · filed 2026-08-13 | -$11.87M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$3.71M 10-Q · filed 2026-05-14 | -$6.73M derived: sum of 2 quarters · filed 2026-05-14 | -$9.00M derived: sum of 3 quarters · filed 2026-05-14 | -$11.30M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$5.29M derived: sum of 2 quarters · filed 2026-03-30 | -$7.59M derived: sum of 3 quarters · filed 2026-08-13 | -$10.97M 10-K · filed 2026-03-30 |
| 2025-09-30 | -$2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$4.57M derived: sum of 2 quarters · filed 2026-08-13 | -$7.95M 10-Q · filed 2025-11-13 | -$10.38M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$5.68M 10-Q · filed 2026-08-13 | -$8.11M derived: sum of 3 quarters · filed 2026-08-13 | -$10.31M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$3.38M 10-Q · filed 2026-05-14 | -$5.81M derived: sum of 2 quarters · filed 2026-05-14 | -$8.01M derived: sum of 3 quarters · filed 2026-05-14 | -$10.30M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$4.62M derived: sum of 2 quarters · filed 2026-03-30 | -$6.92M derived: sum of 3 quarters · filed 2026-03-30 | -$9.13M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$4.49M derived: sum of 2 quarters · filed 2025-11-13 | -$6.70M 10-Q · filed 2025-11-13 | -$8.75M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$4.50M 10-Q · filed 2025-08-14 | -$6.55M derived: sum of 3 quarters · filed 2025-08-14 | -$9.28M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$2.20M 10-Q · filed 2025-05-15 | -$4.26M derived: sum of 2 quarters · filed 2025-05-15 | -$6.99M derived: sum of 3 quarters · filed 2025-05-15 | -$9.76M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | -$4.78M derived: sum of 2 quarters · filed 2025-04-01 | -$7.55M derived: sum of 3 quarters · filed 2025-04-01 | -$10.26M 10-K · filed 2025-04-01 |
| 2023-09-30 | -$2.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$5.50M derived: sum of 2 quarters · filed 2024-11-13 | -$8.21M 10-Q · filed 2024-11-13 | -$9.89M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$2.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$5.48M 10-Q · filed 2024-08-13 | -$7.16M derived: sum of 3 quarters · filed 2024-08-13 | -$9.83M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$2.71M 10-Q · filed 2024-05-10 | -$4.39M derived: sum of 2 quarters · filed 2024-05-10 | -$7.06M derived: sum of 3 quarters · filed 2024-05-10 | -$9.42M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$4.35M derived: sum of 2 quarters · filed 2024-04-01 | -$6.71M derived: sum of 3 quarters · filed 2024-04-01 | -$8.81M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$5.03M derived: sum of 2 quarters · filed 2023-11-13 | -$7.13M 10-Q · filed 2023-11-13 | -$9.69M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | -$4.46M 10-Q · filed 2023-08-16 | -$7.02M derived: sum of 3 quarters · filed 2023-08-16 | -$8.13M derived: sum of 4 quarters · filed 2023-08-16 |
| 2022-03-31 | -$2.10M 10-Q · filed 2023-05-12 | -$4.66M derived: sum of 2 quarters · filed 2023-05-12 | -$5.77M derived: sum of 3 quarters · filed 2023-05-12 | -$7.02M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$3.68M derived: sum of 2 quarters · filed 2023-03-31 | -$4.92M derived: sum of 3 quarters · filed 2023-03-31 | -$5.92M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$2.37M derived: sum of 2 quarters · filed 2022-11-14 | -$3.36M 10-Q · filed 2022-11-14 | -$4.33M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$2.24M 10-Q · filed 2022-08-12 | -$3.21M derived: sum of 3 quarters · filed 2022-08-12 | |
| 2021-03-31 | -$992.00K 10-Q · filed 2022-05-13 | -$1.96M derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | -$970.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$3.53M 10-K · filed 2022-03-30 | ||
| 2020-09-30 | -$2.56M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |